Overview
Key stats
Fundamentals Sep 9- Open
- $92.49
- 52-wk high
- $107.62
- High
- $94.60
- 52-wk low
- $72.76
- Low
- $91.32
- Prev close
- $93.36
- Mkt cap
- $7.72B
- P/E
- 33.7x
- Volume
- 693.9K
- Fwd P/E
- 21.0x
- Beta
- 0.23
- P/S
- 5.7x
- P/B
- 4.0x
- Profit margin
- +17.4%
- Op margin
- +28.4%
- ROE
- +11.4%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Earnings
Earnings came in 5.1% above what analysts expected.
Earnings per share
$0.99 expected
What the street expects next
EPS expected
$1.16 to $1.23
Revenue expected
14 analysts
Last 30 days
Analysts raising estimates
Financials
What it sold, what it cost, what was left.
| USD | Oct 2025 | Jan 2026 | Apr 2026 | Jul 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $322.2M | $334.6M | $354.6M | $350.7M |
| Cost of what it sold | $121.1M | $25.4M | $98.3M | $92.8M |
| Gross profit | $201.1M | $309.2M | $256.3M | $258.0M |
| What it spent | ||||
| Research and development | $65.9M | $70.4M | $67.8M | $73.9M |
| Sales and admin | $30.9M | $146.5M | $31.1M | $34.9M |
| Other operating costs | $24.4M | $24.9M | $54.5M | $50.5M |
| Total operating expenses | $121.2M | $241.8M | $153.4M | $159.3M |
| What was left | ||||
| Operating profit | $79.9M | $67.4M | $103.0M | $98.7M |
| Interest on debt | $14.0M | $13.3M | $12.6M | $12.6M |
| Profit before tax | $67.5M | $60.9M | $92.4M | $87.9M |
| Tax | $15.8M | $11.2M | $23.0M | $22.2M |
| Net profit | $51.7M | $49.7M | $69.4M | $65.6M |
| EBITDA | $120.4M | $100.7M | $106.0M | $142.4M |
Technicals
Price structure
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
25 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bullish
Tone of tracked coverage
Rep. Gilbert Ray Cisneros, Jr. Buys Shares of HealthEquity, Inc. (NASDAQ:HQY)
Leans bullishSep 8Wellington Management Group LLP Reduces Position in HealthEquity, Inc. $HQY
Leans bearishSep 5HealthEquity (NASDAQ:HQY) Lowered to Hold Rating by Wall Street Zen
NeutralSep 5Reasons to Hold HealthEquity Stock in Your Portfolio for Now
Leans bullishSep 4Reasons to Hold HealthEquity Stock in Your Portfolio for Now
BullishSep 4Raymond James reiterates Strong Buy on HealthEquity stock after earnings beat
BullishSep 3Corient Private Wealth LP Buys New Position in HealthEquity, Inc. $HQY
BullishSep 3Raymond James reiterates Strong Buy on HealthEquity stock after earnings beat
BullishSep 3
Macro
24 macro signals shaping HQY right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results